Fulgent Genetics, Inc. (FLGT)
| Market Cap | 882.02M |
| Revenue (ttm) | 618.97M |
| Net Income (ttm) | 143.40M |
| Shares Out | 29.52M |
| EPS (ttm) | 4.63 |
| PE Ratio | 6.43 |
| Forward PE | 7.94 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,242 |
| Open | 30.01 |
| Previous Close | 29.80 |
| Day's Range | 29.79 - 30.30 |
| 52-Week Range | 28.53 - 65.17 |
| Beta | 1.61 |
| Analysts | Buy |
| Price Target | 42.50 (+42.52%) |
| Earnings Date | May 2, 2023 |
About FLGT
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related var... [Read more]
Financial Performance
In 2022, FLGT's revenue was $618.97 million, a decrease of -37.64% compared to the previous year's $992.58 million. Earnings were $143.40 million, a decrease of -71.74%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for FLGT stock is "Buy." The 12-month stock price forecast is $42.5, which is an increase of 42.52% from the latest price.
News
Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year?
Here is how Fulgent Genetics, Inc. (FLGT) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
Is Fulgent Genetics (FLGT) Outperforming Other Medical Stocks This Year?
Here is how Fulgent Genetics, Inc. (FLGT) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
Fulgent Genetics, Inc. (FLGT) Reports Q4 Loss, Tops Revenue Estimates
Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 14.29% and 13.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the sto...
Fulgent Reports Fourth Quarter and Full Year 2022 Financial Results
TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent”, or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therape...
Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel
TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeu...
Fulgent to Participate in the Raymond James & Associates' 44th Annual Institutional Investors Conference
TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established clinical diagnostic business and a therapeutic devel...
Fulgent Genetics to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023
TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing and therapeutics company focused on transforming patient ca...
NOTICE For Investors In NASDAQ: FLGT: Lawsuit Against Fulgent Genetics, Inc. Announced by Shareholders Foundation
San Diego, California--(Newsfile Corp. - January 24, 2023) - The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) share...
INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.'s Directors and Officers for Breach of Fiduciary Duties – FLGT
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors of its continued investigation of cert...
Fulgent Expands Board of Directors with Addition of Reggie Groves
TEMPLE CITY, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics”, “Fulgent” or the “company”) today announced the addition of Reggie Groves to its board of directors, ...
My Top 7 Strong Conviction Buys for 2023
Investors who avoided losing money this year are positioned to consider stocks that are strong conviction buys. An investment idea earns that level of faith when management demonstrates a consistent h...
Fulgent Genetics Stock (FLGT) - Fulgent Investors May Have Legal Claims And Are Encouraged to Contact Kehoe Law Firm, P.C. - Breach of Fiduciary Duties Investigation
Philadelphia, Pennsylvania--(Newsfile Corp. - December 6, 2022) - Kehoe Law Firm, P.C. is investigating whether the directors and/or officers of Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) breac...
The 7 Best Mid-Cap Stocks to Buy Right Now
While the large-capitalization firms attract massive institutional support and the small enterprises grab retail eyeballs, the center lane investments – even those labeled the best mid-cap stocks to b...
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.'s Directors and Officers for Breach of Fiduciary Duties – FLGT
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating certain directors and officers of Fulge...
FINAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 21, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulg...
FLGT FINAL DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors With Losses Over $50K to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
New York, New York--(Newsfile Corp. - November 21, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between...
Fulgent Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 21, 2022 to Discuss Your Rights - FLGT
New York, New York--(Newsfile Corp. - November 21, 2022) - Levi & Korsinsky, LLP notifies investors in Fulgent Genetics, Inc. ("Fulgent" or the "Company") (NASDAQ: FLGT) of a class action securities l...
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - November 21, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics...
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fulgent Investors of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK , Nov. 21, 2022 /PRNewswire/ -- Attention Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on...
FLGT DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Fulgent Genetics, Inc. of Deadline in Securities Fraud Class Action Lawsuit
Radnor, Pennsylvania--(Newsfile Corp. - November 19, 2022) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed a...
DEADLINE MONDAY NOTICE: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / November 18, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics, Inc. ("Fulg...
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of inv...
Fulgent Genetics, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on November 21, 2022 in Securities Fraud Class Action Lawsuit
RADNOR, Pa. , Nov. 18, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Fulgent Ge...
DEADLINE MONDAY REMINDER: The Schall Law Firm Encourages Investors in Fulgent Genetics, Inc. with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - November 18, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fulgent Genetics...
FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022
NEW YORK , Nov. 18, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT). To rece...